John F Milligan - Net Worth and Insider Trading

John F Milligan Net Worth

The estimated net worth of John F Milligan is at least $98 Million dollars as of 2024-09-30. John F Milligan is the President and CEO of Gilead Sciences Inc and owns about 1,165,924 shares of Gilead Sciences Inc (GILD) stock worth over $97 Million. John F Milligan is also the Director of 4D Molecular Therapeutics Inc and owns about 100,000 shares of 4D Molecular Therapeutics Inc (FDMT) stock worth over $1 Million. Details can be seen in John F Milligan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John F Milligan has not made any transactions after 2020-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John F Milligan

To

John F Milligan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John F Milligan owns 3 companies in total, including Pacific Biosciences of California Inc (PACB) , Gilead Sciences Inc (GILD) , and 4D Molecular Therapeutics Inc (FDMT) .

Click here to see the complete history of John F Milligan’s form 4 insider trades.

Insider Ownership Summary of John F Milligan

Ticker Comapny Transaction Date Type of Owner
PACB Pacific Biosciences of California Inc 2013-07-17 director
GILD Gilead Sciences Inc 2017-11-13 director & President & COO and Director
FDMT 4D Molecular Therapeutics Inc 2020-12-15 director

John F Milligan Latest Holdings Summary

John F Milligan currently owns a total of 2 stocks. Among these stocks, John F Milligan owns 1,165,924 shares of Gilead Sciences Inc (GILD) as of November 13, 2017, with a value of $97 Million and a weighting of 98.91%. John F Milligan also owns 100,000 shares of 4D Molecular Therapeutics Inc (FDMT) as of December 15, 2020, with a value of $1 Million and a weighting of 1.09%.

Latest Holdings of John F Milligan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GILD Gilead Sciences Inc 2017-11-13 1,165,924 83.50 97,354,654
FDMT 4D Molecular Therapeutics Inc 2020-12-15 100,000 10.70 1,070,000

Holding Weightings of John F Milligan


John F Milligan Form 4 Trading Tracker

According to the SEC Form 4 filings, John F Milligan has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 220,000 shares on November 13, 2017, which brought John F Milligan around $16 Million.

According to the SEC Form 4 filings, John F Milligan has made a total of 1 transactions in 4D Molecular Therapeutics Inc (FDMT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in 4D Molecular Therapeutics Inc is the acquisition of 100,000 shares on December 15, 2020, which cost John F Milligan around $2 Million.

Insider Trading History of John F Milligan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John F Milligan Trading Performance

GuruFocus tracks the stock performance after each of John F Milligan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John F Milligan is 24.05%. GuruFocus also compares John F Milligan's trading performance to market benchmark return within the same time period. The performance of stocks bought by John F Milligan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John F Milligan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John F Milligan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 16.01 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.02 LIMIT LIMIT LIMIT LIMIT LIMIT

John F Milligan Ownership Network

Ownership Network List of John F Milligan

No Data

Ownership Network Relation of John F Milligan

Insider Network Chart

John F Milligan Owned Company Details

What does Pacific Biosciences of California Inc do?

Who are the key executives at Pacific Biosciences of California Inc?

John F Milligan is the director of Pacific Biosciences of California Inc. Other key executives at Pacific Biosciences of California Inc include See Remarks Jeff Eidel , Chief Operating Officer Oene Mark Van , and Chief Accounting Officer Michele Farmer .

Pacific Biosciences of California Inc (PACB) Insider Trades Summary

Over the past 18 months, John F Milligan made no insider transaction in Pacific Biosciences of California Inc (PACB). Other recent insider transactions involving Pacific Biosciences of California Inc (PACB) include a net sale of 330,945 shares made by Christian O Henry , a net sale of 137,871 shares made by Oene Mark Van , and a net sale of 20,970 shares made by Michele Farmer .

In summary, during the past 3 months, insiders sold 163,678 shares of Pacific Biosciences of California Inc (PACB) in total and bought 0 shares, with a net sale of 163,678 shares. During the past 18 months, 605,839 shares of Pacific Biosciences of California Inc (PACB) were sold and 40,000 shares were bought by its insiders, resulting in a net sale of 565,839 shares.

Pacific Biosciences of California Inc (PACB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Pacific Biosciences of California Inc Insider Transactions

No Available Data

John F Milligan Mailing Address

Above is the net worth, insider trading, and ownership report for John F Milligan. You might contact John F Milligan via mailing address: C/o Gilead Sciences, Inc., 333 Lakeside Drive, Foster City Ca 94404.

Discussions on John F Milligan

No discussions yet.